Striatech News

The Striatech Myopia Suite combines automated refractive state measurement and corneal curvature analysis into one seamless workflow. Developed with Prof. Frank Schaeffel, it enables precise, reliable data collection in small animal myopia research.

We’re excited to see how many research groups are presenting work at ARVO 2026 that includes Striatech technology. To help you navigate the packed program, we’ve highlighted selected talks and posters using our systems — organized by day and disease area.

Striatech is proud to support emerging researchers in ophthalmology through the Striatech Travel Grant, in collaboration with the ARVO Foundation for Eye and Vision Research. For 2026, we are delighted to recognize Yohei Yamashita from Kyoto Furitsu Ika Daigaku (Kyoto Prefectural University of Medicine), Japan, as this year’s Travel Grant recipient.

Join Striatech at ARVO 2026 to connect with our team and explore the newest innovations across our product portfolio.

Striatech conducted an on‑site OptoDrum live demo at the University of Tartu, offering hands‑on insight into automated vision testing in a real laboratory environment. Hosted by Professor Mario Plaas and his research group, the session combined methodological discussion with practical experience in standardized visual function assessment. Similar on‑site demos are available to interested research groups upon request.

This Journal Club highlights research by Rachael Pearson et al. on photoreceptor transplantation. Photoreceptor transplantation has long been proposed as a strategy to restore vision, but in advanced retinal degeneration it remained unclear whether the inner retinal neurons could still accept and process new inputs from donor cells. The study shows that human pluripotent stem cell–derived cone photoreceptors can integrate into end-stage mouse retinas, drive retinal function, and induce behavioral responses, revealing that even severely degenerated retinas retain the capacity to remodel in response to healthy photoreceptors.

Striatech regularly shares concise summaries of recent publications where our solutions for neuroscience testing have been used. Now we’d love to feature your work and highlight new neuroscience insights.

2025 was a year of progress, collaboration and exchange within the vision science community. We are grateful for the trust of our partners and collaborators worldwide and proud to support new discoveries – including our continued contribution to the PRO RETINA Foundation, advancing research and patient care. With new projects on the horizon, we look forward to continuing this journey together in 2026.

This Journal Club features innovative research by Harvard’s Cepko lab, exploring gene-independent strategies to preserve vision in retinitis pigmentosa and other genetic forms of blindness. Using AAVs to enhance metabolic support, including MCT2 expression in retinal pigment epithelial cells, they preserved cone photoreceptors and maintained color and daylight vision across diverse genotypes.

This study by Chandler et al explores a gene-independent approach to preserve vision in retinitis pigmentosa (RP), a genetic disorder causing photoreceptor degeneration. By boosting MCT2 protein in retinal pigment epithelial cells, they enhanced glucose availability and reduced glycolysis, improving cone photoreceptor survival in RP models. This metabolic support strategy could help maintain vision in RP patients regardless of their specific genetic mutation. The OptoDrum provided quantitative measurements of visual function and confirming the therapy’s effectiveness in slowing retinal degeneration.

Meet Striatech at EVER 2025 in Florence – you can find us at at the booth of our partner Phoenix Micron (#2) and discover how our solutions can support your studies and experiments.